LeMaitre Vascular, Inc. (NASDAQ:LMAT) Shares Sold by Rice Hall James & Associates LLC

Rice Hall James & Associates LLC reduced its position in LeMaitre Vascular, Inc. (NASDAQ:LMAT - Free Report) by 10.0% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 235,076 shares of the medical instruments supplier's stock after selling 26,230 shares during the quarter. LeMaitre Vascular accounts for approximately 1.2% of Rice Hall James & Associates LLC's investment portfolio, making the stock its 23rd largest holding. Rice Hall James & Associates LLC owned approximately 1.05% of LeMaitre Vascular worth $21,660,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently made changes to their positions in LMAT. DF Dent & Co. Inc. raised its holdings in shares of LeMaitre Vascular by 26.2% in the third quarter. DF Dent & Co. Inc. now owns 258,767 shares of the medical instruments supplier's stock valued at $24,037,000 after acquiring an additional 53,797 shares in the last quarter. Conestoga Capital Advisors LLC raised its holdings in shares of LeMaitre Vascular by 1.9% in the third quarter. Conestoga Capital Advisors LLC now owns 1,978,351 shares of the medical instruments supplier's stock valued at $183,769,000 after acquiring an additional 36,850 shares in the last quarter. F M Investments LLC grew its stake in LeMaitre Vascular by 36.6% in the third quarter. F M Investments LLC now owns 123,545 shares of the medical instruments supplier's stock valued at $11,476,000 after purchasing an additional 33,087 shares during the last quarter. Barclays PLC grew its stake in LeMaitre Vascular by 394.5% in the third quarter. Barclays PLC now owns 36,577 shares of the medical instruments supplier's stock valued at $3,396,000 after purchasing an additional 29,180 shares during the last quarter. Finally, State Street Corp grew its stake in LeMaitre Vascular by 3.6% in the third quarter. State Street Corp now owns 822,085 shares of the medical instruments supplier's stock valued at $76,363,000 after purchasing an additional 28,525 shares during the last quarter. 84.64% of the stock is currently owned by institutional investors.

LeMaitre Vascular Stock Performance

NASDAQ LMAT traded down $1.13 during trading hours on Friday, reaching $99.79. The stock had a trading volume of 37,315 shares, compared to its average volume of 155,317. LeMaitre Vascular, Inc. has a 52-week low of $59.87 and a 52-week high of $109.58. The stock has a fifty day moving average of $96.05 and a 200 day moving average of $93.97. The stock has a market cap of $2.24 billion, a P/E ratio of 54.68, a price-to-earnings-growth ratio of 2.27 and a beta of 0.96.

Analysts Set New Price Targets

LMAT has been the topic of several analyst reports. Oppenheimer reiterated an "outperform" rating and issued a $93.00 target price (up previously from $90.00) on shares of LeMaitre Vascular in a research note on Friday, November 1st. Barrington Research lifted their target price on LeMaitre Vascular from $92.00 to $93.00 and gave the company an "outperform" rating in a research note on Friday, November 1st. StockNews.com lowered LeMaitre Vascular from a "buy" rating to a "hold" rating in a research note on Friday, December 13th. Finally, Wells Fargo & Company assumed coverage on LeMaitre Vascular in a research note on Thursday, February 13th. They set an "equal weight" rating and a $95.00 price target on the stock. Three investment analysts have rated the stock with a hold rating, six have issued a buy rating and one has assigned a strong buy rating to the company's stock. According to MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average target price of $94.63.

About LeMaitre Vascular

LeMaitre Vascular, Inc develops, manufactures, and markets medical devices and implants used in the field of vascular surgery worldwide. It offers human cadaver tissue cryopreservation services; angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries; thrombectomy catheters for removing thrombi in the venous system; occlusion catheters that temporarily occlude the blood flow; and perfusion catheters to perfuse the blood and other fluids into the vasculature.